According to a recent LinkedIn post from Plenful, the company’s founder and CEO participated in a Learning Lab session at the NHIA 2026 conference, outlining a vision for using AI to transform infusion workflows. The post suggests the platform is aimed at helping infusion teams move faster, reduce manual tasks, and prioritize expedited patient care.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also notes that Plenful’s team is actively engaging with infusion leaders and partners at the event, emphasizing relationship building within the infusion and health system pharmacy segments. For investors, this activity may indicate continued business development efforts in a niche, workflow-automation market, potentially supporting future customer acquisition and partnership-driven growth.
By highlighting AI-driven workflow automation for infusion and pharmacy operations, the post positions Plenful within the broader healthcare technology and automation trend. If the company can translate conference interest into commercial deployments, it could strengthen its competitive profile in healthcare workflow software and create recurring revenue opportunities tied to health system and specialty pharmacy clients.